1 Lin CC, McLachlan AJ, Latimer J, et al. (2016). OPAL: a randomised, placebo-controlled trial of opioid analgesia for the reduction of pain severity in people with acute spinal pain. Trial protocol. BMJ Open 2016;6:e011278. doi: 10.1136/bmjopen-2016-011278
2 Harris, I. A., Naylor, J.M., Lawson, A. et al. (2017). A combined randomised and observational study of surgery for fractures in the distal radius in the elderly (CROSSFIRE)-a study protocol. BMJ Open, 7(6),e016100. doi:10.1136/bmjopen-2017-016100
3 Day RO, Frensham LJ, Nguyen AD, et al. (2017). Effectiveness of an electronic patient centred self-management tool for gout sufferers: a cluster randomised controlled trial protocol. BMJ Open, 7(10),e017281. doi:10.1136/bmjopen-2017-017281
4 Lukaszyk C, Coombes J, Sherrington, C, et al. (2017). The Ironbark program: Implementation and impact of a community‐based fall prevention pilot program for older Aboriginal and Torres Strait Islander people. Health Promot J Austral, 29(2),189-198.
5 Nikles, J, Keijzers, G, Mitchell, G et al. (2018) Pregabalin versus placebo in targeting pro-nociceptive mechanisms to prevent chronic pain after whiplash injury in at-risk individuals a feasibility study for a randomised controlled trial. Trials, 19(1),44. doi 10.1186/s13063-018-2450-9
6 Ferreira, M.L., Harris, I, Latimer, J, et al. (2018), Success surgery for spinal stenosis – protocol of a randomised placebo-controlled trial of surgical decompression. Osteoarthritis and Cartilage, 26,S426
7 Machado GC, Richards B, Needs, C, et al. (2018). Implementation of an evidence-based model of care for low back pain in emergency departments: protocol for the Sydney Health Partners Emergency Department (SHaPED) trial. BMJ Open, 8(4),e019052. doi: 10.1136/bmjopen-2017-019052
8 Sidhu VS, Graves SE, Buchbinder R, et al. (2019). CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study. BMJ Open 2019;9:e031657. doi: 10.1136/bmjopen-2019-031657



1. Bourne A. M., Johnson, R.V., Cyril, S. et al. (2018). Scoping review of priority setting of research topics for musculoskeletal conditionsBMJ Open, 8(12):e023962. doi: 10.1136/bmjopen-2018-023962
Buchbinder, R,  Bourne, A, Latimer, J. et al. (2018). Early development of the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials NetworkIntern Med J. Dec 11. doi: 10.1111/imj.14191



1 Buchbinder R. The formation of the ANZMUSC Clinical Trials Network; lessons learned. ACTA Summit 20018: Building a self-improving healthcare system. 29-30 November 2018, Sydney, Australia
2 Maher C.  Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. September 2018, Duchenne CTN Establishment meeting, Sydney, Australia
3 Buchbinder R. Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. ACTA Impact and Implementation of Clinical Trial Networks. 28 August 2018, Melbourne, Australia
4 Buchbinder R. Establishing the Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network, 23 August 2018, Southern Denmark University, Odense, Denmark
5 Buchbinder R. 2018 Bonica Lecture: Setting the research agenda for improving health care in musculoskeletal disorders. 2018 Australian Pain Society 38thand New Zealand Pain Society Conjoint Annual Scientific Meeting (APS NZPS 2018), 8-11 April 2018, Sydney, Australia (Invited Keynote)
6 Buchbinder R. Establishing a Multi-disciplinary Trials Network – what can we learn from others? 2nd Australia New Zealand Alliance of Cardiovascular Trials, 8 Feb 2018, Melbourne, Australia
7 Buchbinder R. The future of research funding for musculoskeletal disorders in Australia Annual chiropractic researchers’ forum, COCA and Chiro Australia, 13 October 2017, Melbourne, Australia (Invited Plenary)
8 Buchbinder R. The Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. Cochrane Back Workshop, International Back and Neck Pain Research Forum, 12-15 September 2017, Oslo, Norway
9 Buchbinder R. Australian initiatives for Cochrane and clinical trials. BMJD 5th World Congress, 31 August to 3 Sept 2017, Gold Coast, Australia
10 Buchbinder R. ANZMUSC. Osteoarthritis Summit, 30 May 2017, Sydney, Australia
11 Bourne AM, Buchbinder R. Australia & New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network: How and why we began. SHPA Research Think Tank, June 2016, Melbourne, Australia
12 Bourne AM, Whittle, S, Richards B, Maher C, Buchbinder R. Musculoskeletal clinical trials in Australia: What trials are being performed, who is funding them and where are they being published? 54th ARA and RHPA Annual Scientific Meeting, May 2013, Hobart, Australia


1. Taylor W, Buchbinder R, for the ANZMUSC Clinical Trials Network. Development of a multi-attribute tool for setting priorities for trials in the musculoskeletal field. A project of the Australia and New Zealand Musculoskeletal (ANZMUSC) Clinical Trials Network. 7thAnnual NHMRC Symposium on Research Translation, Sydney, Australia, 27-28 November 2018

Bourne AM, Johnston RV, Cyril S, Briggs AM, Clavisi O, Duque G, Harris IA, Hill C, Hiller C, Kamper SJ, Latimer J, Lawson A, Lin C-W C, Maher CG, Perriman D, Richards BL, Smitham P, Taylor WJ, Whittle S, Buchbinder R.  A systematic review of priority-setting of research topics for musculoskeletal conditions. 7th Annual NHMRC Symposium on Research Translation, Sydney, Australia, 27-28 November 2018